The Rapid Rise of GLP-1s Is Reshaping the Global Pharmaceutical Market
GLP-1 Growth Is Reshaping the Economics of the World’s Leading Medicines The extraordinary commercial growth of GLP-1 medicines is beginning to redefine what a pharmaceutical high-revenue medicine can look like. Historically, the world’s largest-selling medicines built their revenues over long periods. Humira, for example, generated an estimated $320 billion in cumulative inflation-adjusted revenue over approximately…